Menu

Life Sciences Case Studies

RSM provides a variety of tax, accounting and consulting services to innovative life sciences organizations throughout the country, including pharmaceuticals, biopharmaceuticals, biotechnology, clinical research, and medical device manufacturers and suppliers. In the case studies below, learn how our clients have benefitted from working with RSM.

RSM rapidly implements NetSuite for growing life sciences company

RSM’s NetSuite experience and industry knowledge helped Apellis implement a comprehensive NetSuite solution in a short timeline.

Rhythm Pharmaceuticals partners with RSM to implement a new ERP

Rhythm Pharmaceuticals discusses how RSM helped make a success with their recent implementation of a new ERP system.

Rhythm Pharmaceuticals implements Microsoft Dynamics 365

VP & Corporate Controller, John Hulburt, discusses Rhythm's recent implementation of the Microsoft Dynamics 365 ERP.

RSM frees pharmaceutical services company from implementation gridlock

RSM helped Tanner Pharma overcome challenges with its NetSuite implementation provider, setting a foundation for growth and ongoing support.

Managed IT Services helps life sciences company manage growth demands

RSM’s industry and technical knowledge provided Egalet with a managed IT strategy to align organizational goals with technology solutions.

With basic functions improved, a company can focus on strategy

Covance, a life sciences company, wanted to improve its approach to managing global reporting and compliance requirements.

RSM’s FAO helps support pharmaceutical company’s growth initiatives

RSM built a finance and accounting outsourcing solution to help a growing company enhance performance, reduce costs and optimize operations.

Valuation needs in the life sciences industry are anything but generic

This case study focuses on the importance of a deep understanding in life sciences company valuations. Learn more.

RSM helps emerging life sciences company increase financial visibility

RSM worked with InteguRX to develop a comprehensive FAO solution for more financial visibility and consistency that will scale with growth.

Corporate tax outsourcing arrangement gives client the depth it needed

Learn how RSM helped a pharmaceutical company realize better, timelier service through a tax outsourcing arrangement.

Life Sciences Company Streamlines Purchasing and Payments with NetSuite

RSM helped Moderna implement a NetSuite purchasing and payment solution with increased process automation, efficiency and accountability.

RSM helps biopharmaceutical company save IPO price

With IPO on the line, RSM delivers valuation client needs to finance the future.

Review recovers millions in royalties for life sciences company

Royalty review discovers omitted products, unallowable deductions, unreported sales and nearly $4.5 million in underpaid royalties.

Osmotica Pharmaceutical

Hear Michael Gesser, VP of Finance and Treasurer of Osmotica Pharmaceutical, discuss how Microsoft Dynamics positioned them for growth.

RSM’s spectrum of services supports pharmaceutical company’s success

RSM’s integrated delivery platform gave Amring Pharmaceuticals increased visibility into business processes, efficiency and independence.

Life Sciences Insights

( * = Required fields)

Contact Our Team

John Lanza  
National Life Sciences Practice Leader

800.274.3978
John.Lanza@rsmus.com



EVENTS / WEBCASTS

IN-PERSON EVENT

Healthcare and Life Sciences Private Equity and Finance Conference

Healthcare-focused private equity, lending and finance conference will explore ways to successfully close transactions and achieve growth.

  • February 19, 2020

ON DEMAND WEBCAST

Revenue recognition: Key considerations for the life sciences industry

View this webcast to learn how the new revenue recognition standard (ASC 606) affects the life sciences industry (CPE eligible).

RECORDED WEBCAST

What does the Tax Cuts and Jobs Act mean for life sciences companies?

This recorded webcast provides an overview of the key provisions of the new tax bill and how they affect life sciences companies.

  • March 08, 2018